- Home
- ADVB vs GOVX Comparison
ADVB vs GOVX Comparison
Compare ADVB & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- GOVX
- Stock Information
- Founded
- ADVB 2014
- GOVX 2001
- Country
- ADVB United States
- GOVX United States
- Employees
- ADVB N/A
- GOVX N/A
- Industry
- ADVB Medical Specialities
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- GOVX Health Care
- Exchange
- ADVB Nasdaq
- GOVX Nasdaq
- Market Cap
- ADVB 9.1M
- GOVX 7.6M
- IPO Year
- ADVB 2025
- GOVX N/A
- Fundamental
- Price
- ADVB $0.42
- GOVX $0.70
- Analyst Decision
- ADVB
- GOVX Strong Buy
- Analyst Count
- ADVB 0
- GOVX 3
- Target Price
- ADVB N/A
- GOVX $10.67
- AVG Volume (30 Days)
- ADVB 371.2K
- GOVX 721.4K
- Earning Date
- ADVB 11-03-2025
- GOVX 07-28-2025
- Dividend Yield
- ADVB N/A
- GOVX N/A
- EPS Growth
- ADVB N/A
- GOVX N/A
- EPS
- ADVB N/A
- GOVX N/A
- Revenue
- ADVB N/A
- GOVX $6,143,044.00
- Revenue This Year
- ADVB N/A
- GOVX N/A
- Revenue Next Year
- ADVB N/A
- GOVX N/A
- P/E Ratio
- ADVB N/A
- GOVX N/A
- Revenue Growth
- ADVB N/A
- GOVX 1943.07
- 52 Week Low
- ADVB $0.34
- GOVX $0.43
- 52 Week High
- ADVB $4.10
- GOVX $4.29
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- GOVX 41.96
- Support Level
- ADVB N/A
- GOVX $0.71
- Resistance Level
- ADVB N/A
- GOVX $0.77
- Average True Range (ATR)
- ADVB 0.00
- GOVX 0.05
- MACD
- ADVB 0.00
- GOVX -0.00
- Stochastic Oscillator
- ADVB 0.00
- GOVX 19.32
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.